What's new
  • Happy Birthday ICMag! Been 20 years since Gypsy Nirvana created the forum! We are celebrating with a 4/20 Giveaway and by launching a new Patreon tier called "420club". You can read more here.
  • Important notice: ICMag's T.O.U. has been updated. Please review it here. For your convenience, it is also available in the main forum menu, under 'Quick Links"!

:::::::Indiana Cannabis Reform Legislation::::::

pipeline

Cannabotanist
ICMag Donor
Veteran
The leaders of the House and Senate emphasized that cannabis reform could not be discussed this year because the 2-year budget had already been determined in 2023.

Why was there no issue creating a fiscal impact to establish a Psilicybin Treatment Program?

Also Psilocybin is a Schedule 1 Drug in the Controlled Substances Act, so why was there a difference in how this hallucinogen was considered for medical use compared to cannabis?

There is apparent discrimination by this legislative body against discussion of studying or utilizing cannabis as a medicine.
______________________________________________________


LEGISLATIVE SERVICES AGENCY
OFFICE OF FISCAL AND MANAGEMENT ANALYSIS
200 W. Washington St., Suite 301
Indianapolis, IN 46204
(317) 233-0696
iga.in.gov
FISCAL IMPACT STATEMENT
LS 6465 NOTE PREPARED: Feb 6, 2024
BILL NUMBER: SB 139 BILL AMENDED: Feb 1, 2024
SUBJECT: Psilocybin Treatment Program.
FIRST AUTHOR: Sen. Charbonneau BILL STATUS: As Passed Senate
FIRST SPONSOR: Rep. Carbaugh
FUNDS AFFECTED: GENERAL IMPACT: State
X DEDICATED
FEDERAL
Summary of Legislation: The bill establishes the Therapeutic Psilocybin Research Fund, administered by
the Indiana State Department of Health (IDOH), to provide financial assistance to research institutions in
Indiana to study the use of psilocybin to treat mental health and other medical conditions. It sets forth clinical
study requirements. The bill requires a research institution that receives a grant to conduct a clinical study
to prepare and submit a report to the Interim Study Committee on Public Health, Behavioral Health, and
Human Services, the IDOH, and the Division of Mental Health and Addiction.
Effective Date: Upon passage.
Explanation of State Expenditures: The bill establishes the nonreverting Therapeutic Psilocybin Research
Fund (Fund) to provide financial assistance to research institutions in Indiana that receive a grant to conduct
clinical studies on the use of Psilocybin as an alternative treatment for mental health and other medical
conditions. The Fund would be administered by the IDOH and would consist of money received from state
or federal grants and programs, gifts, donations, or transfers made to the Fund. Expenditures needed by the
IDOH to administer the Fund would be paid from money in the Fund. Money within the Fund would be
continuously appropriated for psilocybin research as described within the bill. [The IDOH’s administrative
expenditures are currently paid from the Tobacco Master Settlement Fund, a dedicated fund.]
Any increase in General Fund expenditures would depend upon the level of appropriations made to the Fund
by future acts of the General Assembly. The IDOH would be required to establish the administration process
for the Fund and applications to the Fund by July 1, 2024.
Explanation of State Revenues

Explanation of Local Expenditures:
Explanation of Local Revenues:
State Agencies Affected: General Assembly; Indiana Department of Health; Office of Medicaid Policy and
Planning, Family and Social Services Administration.
Local Agencies Affected:
Information Sources:
Fiscal Analyst: Chris Baker, 317-232-985
 

pipeline

Cannabotanist
ICMag Donor
Veteran
1707855350789.jpeg

Senate Bill 139 has no amendments, and will not include a medical cannabis program as amendment #1 would have done in HB139.

However, there was an amendment to SB 139 by the House Public Health Comittee which would include alcohol and tobacco use disorder to the list of types of diseases to treat.
_____________________________________________________________________

From Marijuanamoment.net article posted above:

"Before approving the bill on Tuesday, the House committee adopted an amendment to add alcohol use disorder and tobacco use disorder to list of conditions as well.

The studies supported by the legislation would need to “compare the efficacy of psilocybin as a treatment for mental health and other medical conditions…with the efficacy of other current treatment options.”

The bill would become effective immediately upon passage, as it was filed as an emergency measure. Officials would need to establish a process to administer the fund and process applications by July 1.

House panel members heard testimony from a number of people who have directly benefited from psychedelic-assisted therapy as well as from former Indiana State Health Commissioner Richard Feldman.

“Utilizing a psychedelic drug for the treatment of emotional disorders may seem pretty crazy at first consideration,” Feldman, who now represents the Indiana Academy of Family Physicians, told the committee. “But recent studies have shown impressive results, conducted by respected institutions, reported in mainstream medical journals.”"
 
Last edited:

pipeline

Cannabotanist
ICMag Donor
Veteran

PROPOSED AMENDMENT
SB 139 # 5
DIGEST
Therapeutic psilocybin research fund. For provisions allowing a research institution in Indiana to apply
to receive financial assistance from the fund to study the use of psilocybin to treat mental health and other
medical conditions, adds alcohol use disorder and tobacco use disorder to the list of mental health and other
medical conditions.
1 Page 3, between lines 18 and 19, begin a new line block indented
2 and insert:
3 "(7) Alcohol use disorder.
4 (8) Tobacco use disorder.".
(Reference is to SB 139 as printed February 2, 2024.)
 

pipeline

Cannabotanist
ICMag Donor
Veteran
I think I solved the riddle. Wondering why the federal government is so oppressive against the states and cities who are waiting on a formal approval before they open the market for the cannabis industry.
When it comes down to it, money is the bottom line. Continuing this selective prohibition, where some states are forced to wait to open for business, is a way to promote the economy in the states who have adopted Democrat policies, and inhibit the economy in states with Republican policies.
All the capitol cities throughout the nation would like to open for business, so it welcomes visitors with comfortable hospitality, and increases tax revenue.
The major cities like Chicago, New York, Detroit, Seattle, St. Louis, these all have adopted cannabis legalization and their industries are getting a head start, promoting their state economy. This is working toward the continuing goal of trying to control the people through forcing them to move to these highly digital grid surveillance mega-cities.
Cannabis is just a pawn in their game. The elite don't care about giving you liberty to use cannabis as medicine, its just part of their wicked program to consolidate wealth and control for themselves.
 

pipeline

Cannabotanist
ICMag Donor
Veteran
With Covid restrictions in all the Democrat controlled mega-cities, maybe having cannabis legal in these areas was compensation for the economic losses from Covid restrictions they chose to put in place.
What I find interesting it the areas where Covid restrictions were most oppressive and heavily enforced is where cannabis is legalized. See the control structure forming?
Also was cannabis a reward for going through the tougher restrictions and vaccine mandates?
Are the states being allowed to have legal cannabis as a financial compensation for the economic losses from adopting oppressive and destructive CoVid restrictions?
 

pipeline

Cannabotanist
ICMag Donor
Veteran
 

pipeline

Cannabotanist
ICMag Donor
Veteran
Senate Committee on Commerce and Technology held a hearing on HB1079 Low-THC Hemp Extract today, but it was hearing only. The Senate Comittee may not hold another hearing on the bill and it will die in committee.

Businesses who sell or manufacture these products will continue to operate un-regulated, and age restrictions have yet to be set for these products.

Hemp derived products are expicitly exempt from the definition of Marijuana/Hashish under the CSA, and have been legalized by the 2018 Farm Bill. However there has yet to be a regulatory framework set by the federal government reguarding these hemp derived products.

State enforcement agencies, the Indiana's Prosecuting council and Indiana State Police testified in opposition to the bill. They have yet to prosecute anyone for hemp derived substances because its not clear whether or not the products are illegal, and there has yet to be a criminal case decided on by the courts.

Business owners located in the state spoke up in support of the bill, saying the current uncertainty is detrimental and costly.

 

pipeline

Cannabotanist
ICMag Donor
Veteran

 
Top